269 related articles for article (PubMed ID: 31623141)
1. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
[TBL] [Abstract][Full Text] [Related]
2. Recognition of breathprints of lung cancer and chronic obstructive pulmonary disease using the Aeonose
Krauss E; Haberer J; Barreto G; Degen M; Seeger W; Guenther A
J Breath Res; 2020 Jul; 14(4):046004. PubMed ID: 32325432
[TBL] [Abstract][Full Text] [Related]
3. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.
Moor CC; Oppenheimer JC; Nakshbandi G; Aerts JGJV; Brinkman P; Maitland-van der Zee AH; Wijsenbeek MS
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732331
[TBL] [Abstract][Full Text] [Related]
5. Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank.
Krauss E; Froehler M; Degen M; Mahavadi P; Dartsch RC; Korfei M; Ruppert C; Seeger W; Guenther A
J Clin Med; 2019 May; 8(5):. PubMed ID: 31075945
[No Abstract] [Full Text] [Related]
6. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
7. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
Cameli P; Bargagli E; Bergantini L; Refini RM; Pieroni M; Sestini P; Rottoli P
J Breath Res; 2019 Mar; 13(2):026008. PubMed ID: 30690441
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
[TBL] [Abstract][Full Text] [Related]
10. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
[TBL] [Abstract][Full Text] [Related]
11. The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals.
Guo B; Wang L; Xia S; Mao M; Qian W; Peng X; Zheng Z; Chen R; Han Q; Luo Q
J Thorac Dis; 2020 Jul; 12(7):3688-3696. PubMed ID: 32802448
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
13. The role of nailfold capillaroscopy in interstitial lung diseases - can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases?
Çakmakçı Karadoğan D; Balkarlı A; Önal Ö; Altınışık G; Çobankara V
Tuberk Toraks; 2015; 63(1):22-30. PubMed ID: 25849052
[TBL] [Abstract][Full Text] [Related]
14. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
15. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.
Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO
BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374
[TBL] [Abstract][Full Text] [Related]
16. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
[TBL] [Abstract][Full Text] [Related]
17. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
18. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
20. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
